Literature DB >> 12897212

Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1).

Gaël Ménasché1, Chen Hsuan Ho, Ozden Sanal, Jérôme Feldmann, Ilhan Tezcan, Fügen Ersoy, Anne Houdusse, Alain Fischer, Geneviève de Saint Basile.   

Abstract

Griscelli syndrome (GS) is a rare autosomal recessive disorder that associates hypopigmentation, characterized by a silver-gray sheen of the hair and the presence of large clusters of pigment in the hair shaft, and the occurrence of either a primary neurological impairment or a severe immune disorder. Two different genetic forms, GS1 and GS2, respectively, account for the mutually exclusive neurological and immunological phenotypes. Mutations in the gene encoding the molecular motor protein Myosin Va (MyoVa) cause GS1 and the dilute mutant in mice, whereas mutations in the gene encoding the small GTPase Rab27a are responsible for GS2 and the ashen mouse model. We herein present genetic and functional evidence that a third form of GS (GS3), whose expression is restricted to the characteristic hypopigmentation of GS, results from mutation in the gene that encodes melanophilin (Mlph), the ortholog of the gene mutated in leaden mice. We also show that an identical phenotype can result from the deletion of the MYO5A F-exon, an exon with a tissue-restricted expression pattern. This spectrum of GS conditions pinpoints the distinct molecular pathways used by melanocytes, neurons, and immune cells in secretory granule exocytosis, which in part remain to be unraveled.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897212      PMCID: PMC166299          DOI: 10.1172/JCI18264

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.

Authors:  G Ménasché; E Pastural; J Feldmann; S Certain; F Ersoy; S Dupuis; N Wulffraat; D Bianchi; A Fischer; F Le Deist; G de Saint Basile
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Two genes are responsible for Griscelli syndrome at the same 15q21 locus.

Authors:  E Pastural; F Ersoy; N Yalman; N Wulffraat; E Grillo; F Ozkinay; I Tezcan; G Gediköglu; N Philippe; A Fischer; G de Saint Basile
Journal:  Genomics       Date:  2000-02-01       Impact factor: 5.736

3.  Homeostatic regulation of CD8+ T cells by perforin.

Authors:  D Kägi; B Odermatt; T W Mak
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

4.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

Authors:  S E Stepp; R Dufourcq-Lagelouse; F Le Deist; S Bhawan; S Certain; P A Mathew; J I Henter; M Bennett; A Fischer; G de Saint Basile; V Kumar
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

5.  A mutation in Rab27a causes the vesicle transport defects observed in ashen mice.

Authors:  S M Wilson; R Yip; D A Swing; T N O'Sullivan; Y Zhang; E K Novak; R T Swank; L B Russell; N G Copeland; N A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

6.  Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients.

Authors:  Gaël Menasche; Jérôme Feldmann; Anne Houdusse; Catherine Desaymard; Alain Fischer; Bruno Goud; Genèvieve de Saint Basile
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

7.  The sequence of the human genome.

Authors:  J C Venter; M D Adams; E W Myers; P W Li; R J Mural; G G Sutton; H O Smith; M Yandell; C A Evans; R A Holt; J D Gocayne; P Amanatides; R M Ballew; D H Huson; J R Wortman; Q Zhang; C D Kodira; X H Zheng; L Chen; M Skupski; G Subramanian; P D Thomas; J Zhang; G L Gabor Miklos; C Nelson; S Broder; A G Clark; J Nadeau; V A McKusick; N Zinder; A J Levine; R J Roberts; M Simon; C Slayman; M Hunkapiller; R Bolanos; A Delcher; I Dew; D Fasulo; M Flanigan; L Florea; A Halpern; S Hannenhalli; S Kravitz; S Levy; C Mobarry; K Reinert; K Remington; J Abu-Threideh; E Beasley; K Biddick; V Bonazzi; R Brandon; M Cargill; I Chandramouliswaran; R Charlab; K Chaturvedi; Z Deng; V Di Francesco; P Dunn; K Eilbeck; C Evangelista; A E Gabrielian; W Gan; W Ge; F Gong; Z Gu; P Guan; T J Heiman; M E Higgins; R R Ji; Z Ke; K A Ketchum; Z Lai; Y Lei; Z Li; J Li; Y Liang; X Lin; F Lu; G V Merkulov; N Milshina; H M Moore; A K Naik; V A Narayan; B Neelam; D Nusskern; D B Rusch; S Salzberg; W Shao; B Shue; J Sun; Z Wang; A Wang; X Wang; J Wang; M Wei; R Wides; C Xiao; C Yan; A Yao; J Ye; M Zhan; W Zhang; H Zhang; Q Zhao; L Zheng; F Zhong; W Zhong; S Zhu; S Zhao; D Gilbert; S Baumhueter; G Spier; C Carter; A Cravchik; T Woodage; F Ali; H An; A Awe; D Baldwin; H Baden; M Barnstead; I Barrow; K Beeson; D Busam; A Carver; A Center; M L Cheng; L Curry; S Danaher; L Davenport; R Desilets; S Dietz; K Dodson; L Doup; S Ferriera; N Garg; A Gluecksmann; B Hart; J Haynes; C Haynes; C Heiner; S Hladun; D Hostin; J Houck; T Howland; C Ibegwam; J Johnson; F Kalush; L Kline; S Koduru; A Love; F Mann; D May; S McCawley; T McIntosh; I McMullen; M Moy; L Moy; B Murphy; K Nelson; C Pfannkoch; E Pratts; V Puri; H Qureshi; M Reardon; R Rodriguez; Y H Rogers; D Romblad; B Ruhfel; R Scott; C Sitter; M Smallwood; E Stewart; R Strong; E Suh; R Thomas; N N Tint; S Tse; C Vech; G Wang; J Wetter; S Williams; M Williams; S Windsor; E Winn-Deen; K Wolfe; J Zaveri; K Zaveri; J F Abril; R Guigó; M J Campbell; K V Sjolander; B Karlak; A Kejariwal; H Mi; B Lazareva; T Hatton; A Narechania; K Diemer; A Muruganujan; N Guo; S Sato; V Bafna; S Istrail; R Lippert; R Schwartz; B Walenz; S Yooseph; D Allen; A Basu; J Baxendale; L Blick; M Caminha; J Carnes-Stine; P Caulk; Y H Chiang; M Coyne; C Dahlke; A Deslattes Mays; M Dombroski; M Donnelly; D Ely; S Esparham; C Fosler; H Gire; S Glanowski; K Glasser; A Glodek; M Gorokhov; K Graham; B Gropman; M Harris; J Heil; S Henderson; J Hoover; D Jennings; C Jordan; J Jordan; J Kasha; L Kagan; C Kraft; A Levitsky; M Lewis; X Liu; J Lopez; D Ma; W Majoros; J McDaniel; S Murphy; M Newman; T Nguyen; N Nguyen; M Nodell; S Pan; J Peck; M Peterson; W Rowe; R Sanders; J Scott; M Simpson; T Smith; A Sprague; T Stockwell; R Turner; E Venter; M Wang; M Wen; D Wu; M Wu; A Xia; A Zandieh; X Zhu
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

8.  Rab27a enables myosin Va-dependent melanosome capture by recruiting the myosin to the organelle.

Authors:  X Wu; K Rao; M B Bowers; N G Copeland; N A Jenkins; J A Hammer
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

9.  Rab27a is required for regulated secretion in cytotoxic T lymphocytes.

Authors:  J C Stinchcombe; D C Barral; E H Mules; S Booth; A N Hume; L M Machesky; M C Seabra; G M Griffiths
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

10.  Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice.

Authors:  E K Haddad; X Wu; J A Hammer; P A Henkart
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  72 in total

Review 1.  Principles of unconventional myosin function and targeting.

Authors:  M Amanda Hartman; Dina Finan; Sivaraj Sivaramakrishnan; James A Spudich
Journal:  Annu Rev Cell Dev Biol       Date:  2011-05-31       Impact factor: 13.827

2.  Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells.

Authors:  Maaike Neeft; Marnix Wieffer; Arjan S de Jong; Gabriela Negroiu; Corina H G Metz; Alexander van Loon; Janice Griffith; Jeroen Krijgsveld; Nico Wulffraat; Henriette Koch; Albert J R Heck; Nils Brose; Monique Kleijmeer; Peter van der Sluijs
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

Review 3.  Mechanisms of protein delivery to melanosomes in pigment cells.

Authors:  Anand Sitaram; Michael S Marks
Journal:  Physiology (Bethesda)       Date:  2012-04

Review 4.  Coat color and coat color pattern-related neurologic and neuro-ophthalmic diseases.

Authors:  Aubrey A Webb; Cheryl L Cullen
Journal:  Can Vet J       Date:  2010-06       Impact factor: 1.008

5.  Light microscopic examination of scalp hair samples as an aid in the diagnosis of paediatric disorders: retrospective review of more than 300 cases from a single centre.

Authors:  V V Smith; G Anderson; M Malone; N J Sebire
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

6.  Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.

Authors:  Setareh Mamishi; Mohammad Hossein Modarressi; Babak Pourakbari; Banafshe Tamizifar; Fatemeh Mahjoub; Alireza Fahimzad; Soheila Alyasin; Mohamad Hassan Bemanian; Amir Ali Hamidiyeh; Mohammad Reza Fazlollahi; Mahmoud Reza Ashrafi; Anna Isaeian; Ghamartaj Khotaei; Mehdi Yeganeh; Nima Parvaneh
Journal:  J Clin Immunol       Date:  2008-03-19       Impact factor: 8.317

Review 7.  Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Authors:  Marjan Huizing; Amanda Helip-Wooley; Wendy Westbroek; Meral Gunay-Aygun; William A Gahl
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

8.  A Comparative Transcriptomic Analysis of Development in Two Astyanax Cavefish Populations.

Authors:  Bethany A Stahl; Joshua B Gross
Journal:  J Exp Zool B Mol Dev Evol       Date:  2017-06-14       Impact factor: 2.656

9.  The GTPase-deficient Rab27A(Q78L) mutant inhibits melanosome transport in melanocytes through trapping of Rab27A effector protein Slac2-a/melanophilin in their cytosol: development of a novel melanosome-targetinG tag.

Authors:  Morié Ishida; Saki P Arai; Norihiko Ohbayashi; Mitsunori Fukuda
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

10.  Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.

Authors:  M Al-Mofareh; M Ayas; A Al-Seraihy; K Siddiqui; A Al-Jefri; I Ghemlas; H Alsaedi; H El-Solh; S Al-Sweedan; B Al-Saud; H Al-Mousa; H Al-Dhekri; R Arnaout; R Mohammed; S Al-Muhsen; A Al-Ahmari
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.